Illustration for: North America VC Funding Fell 35% In Q3 Despite AI Boom

North America VC Funding Fell 35% In Q3 Despite AI Boom

North American startups raised $92 billion in Q3 2026, down 35% from Q2's megaround-fueled high but up 50% year over year, as AI companies captured roughly two-thirds of all venture dollars, per Crunchbase.

By the Numbers

$92B
Q3 total raised
-35%
vs Q2 2026
+50%
vs Q3 2025
~$61B (~66%)
AI share of total
$66.45B
Late-stage total
ShareXLinkedInEmail

THE RUNDOWN

1

The 35% quarter-over-quarter drop isn't a venture slowdown โ€” it's the absence of the OpenAI and Anthropic megarounds that inflated Q1 ($110B) and Q2 ($65B) to begin with, per Crunchbase's own framing.

2

AI companies still captured roughly two-thirds of all North American venture dollars in Q3, one of the highest concentrations on record, meaning non-AI startups are competing for a shrinking slice of a shrinking pie.

3

Early-stage funding held well above year-ago levels even as it slipped from Q2's peak, suggesting seed and Series A investors haven't pulled back despite later-stage megaround fatigue.

4

Only 17 venture-backed companies went public in North America in Q3, raising under $4 billion combined with zero blockbuster tech listings โ€” the IPO window Anthropic and OpenAI are both eyeing hasn't actually opened yet.

The VC Read

Value Add VC analysis

The number that should worry non-AI founders isn't the 35% drop, it's the 66% concentration: with AI companies absorbing two-thirds of every venture dollar in Q3, a healthtech or fintech Series B now competes directly against an AI infra round for the same LP capital, not against other healthtech deals. Track late-stage non-AI round sizes next quarter โ€” if they keep shrinking while AI late-stage holds at $66B+, that's the real story a single quarterly number currently flattens.

Analysis

North American startups raised $92 billion across seed through growth stages in Q3 2026, Crunchbase News reported โ€” down 35% from Q2 but up 50% year over year.

Crunchbase attributes the quarter-over-quarter drop largely to the absence of new OpenAI- and Anthropic-sized megarounds: OpenAI's round alone pulled in $110 billion in Q1, and Anthropic's pulled in $65 billion in Q2. Deal counts stayed roughly flat.

AI-focused companies still took roughly two-thirds of total funding โ€” about $61 billion โ€” one of the highest concentrations Crunchbase has tracked.

โ€œAI-focused companies still took roughly two-thirds of total funding โ€” about $61 billion โ€” one of the highest concentrations Crunchbase has tracked.โ€

Late-stage funding reached $66.45 billion, up about a third year over year, with more than a dozen rounds clearing $1 billion:

  • Databricks โ€” $5 billion round.
  • Crusoe โ€” $3.9 billion raise.

Early-stage funding came in at $20.6 billion โ€” down from Q2's peak but well above year-ago levels, led by River AI's $1.1 billion Series A.

M&A stayed active: Nvidia's $12.93 billion purchase of Hugging Face was the quarter's biggest deal, followed by AMD's roughly $8.2 billion stock acquisition of World Labs. Eleven North American startup acquisitions topped $1 billion.

IPOs stayed thin: just 17 venture-backed companies went public, raising under $4 billion combined, with no blockbuster tech debut โ€” Crunchbase notes Q2's SpaceX listing makes the comparison lopsided. Anthropic is reportedly eyeing a public listing as early as November, with OpenAI's confidential filing from June still pointing toward a 2027 debut.

ShareXLinkedInEmail

Key Sources

2 sources

THE WIRE in your inboxโ€” Tech, startup & VC news with The VC Read, a few times a week. Free to subscribe, no spam.